MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Noh, Ji Heon | - |
dc.contributor.author | Chang, Young Gyoon | - |
dc.contributor.author | Kim, Min Gyu | - |
dc.contributor.author | Jung, Kwang Hwa | - |
dc.contributor.author | Kim, Jeong Kyu | - |
dc.contributor.author | Bae, Hyun Jin | - |
dc.contributor.author | Eun, Jung Woo | - |
dc.contributor.author | Shen, Qingyu | - |
dc.contributor.author | Kim, Seung-Jin | - |
dc.contributor.author | Kwon, So Hee | - |
dc.contributor.author | Park, Won Sang | - |
dc.contributor.author | Lee, Jung Young | - |
dc.contributor.author | Nam, Suk Woo | - |
dc.date.accessioned | 2023-03-08T20:56:53Z | - |
dc.date.available | 2023-03-08T20:56:53Z | - |
dc.date.issued | 2013-07 | - |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.issn | 1872-7980 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/64833 | - |
dc.description.abstract | Aberrant regulation of histone deacetylase 2 (HDAC2) plays a pivotal role in the development of hepatocellular carcinoma (HCC), but, the underlying mechanism leading to HDAC2 overexpression is not well understood. We performed microRNA (miRNA) profiling analysis in a subset of HCCs, and identified four down-regulated miRNAs that may target HDAC2 in HCC. Ectopic expression of miRNA mimics evidenced that miR-145 suppresses HDAC2 expression in HCC cells. This treatment repressed cancer cell growth and recapitulated HDAC2 knockdown effects on HCC cells. In conclusion, we suggest that loss or suppression of miR-145 may cause aberrant overexpression of HDAC2 and promote HCC tumorigenesis. (C) 2013 Elsevier Ireland Ltd. All rights reserved. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.title | MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.canlet.2013.03.003 | - |
dc.identifier.bibliographicCitation | CANCER LETTERS, v.335, no.2, pp 455 - 462 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000320682500024 | - |
dc.identifier.scopusid | 2-s2.0-84878249332 | - |
dc.citation.endPage | 462 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 455 | - |
dc.citation.title | CANCER LETTERS | - |
dc.citation.volume | 335 | - |
dc.type.docType | Article | - |
dc.publisher.location | 아일랜드 | - |
dc.subject.keywordAuthor | HDAC2 | - |
dc.subject.keywordAuthor | Liver cancer | - |
dc.subject.keywordAuthor | MiR-145 | - |
dc.subject.keywordAuthor | Tumor suppressor | - |
dc.subject.keywordPlus | INCREASED EXPRESSION | - |
dc.subject.keywordPlus | MICRORNAS | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | STRATEGIES | - |
dc.subject.keywordPlus | INDUCTION | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | HDACS | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.